Targeting the VEGFR2 Signaling Pathway for Angiogenesis and Fibrosis Regulation in Neovascular Age-Related Macular Degeneration

To investigate the potential therapeutic effects of targeting the vascular endothelial growth factor (VEGF) signaling pathway using apatinib investigators employed in vitro and in vivo models of neovascular age-related macular degeneration.